Staged decline of neuronal function in vivo in an animal model of Alzheimer's disease.
about
Defining the earliest pathological changes of Alzheimer's diseaseMicrofluidic chemotaxis platform for differentiating the roles of soluble and bound amyloid-β on microglial accumulation.Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo.Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding Aβ plaques by iGluSnFR two-photon imaging.Early and progressive deficit of neuronal activity patterns in a model of local amyloid pathology in mouse prefrontal cortexBACE1 is necessary for experience-dependent homeostatic synaptic plasticity in visual cortexAmyloid-beta: a crucial factor in Alzheimer's disease.The polyphenol oleuropein aglycone protects TgCRND8 mice against Aß plaque pathology.Impairments in experience-dependent scaling and stability of hippocampal place fields limit spatial learning in a mouse model of Alzheimer's disease.Massachusetts Alzheimer's Disease Research Center: progress and challenges.Abnormal Population Responses in the Somatosensory Cortex of Alzheimer's Disease Model Mice.Behavioral-state modulation of inhibition is context-dependent and cell type specific in mouse visual cortex.Early Cortical Changes in Gamma Oscillations in Alzheimer's DiseaseSoluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain.Genetic strategies to investigate neuronal circuit properties using stem cell-derived neurons.Network-wide dysregulation of calcium homeostasis in Alzheimer's disease.Imaging of cerebrovascular pathology in animal models of Alzheimer's diseaseNeuronal hyperactivity--A key defect in Alzheimer's disease?Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.BACE inhibition-dependent repair of Alzheimer's pathophysiology.Oleuropein aglycone and polyphenols from olive mill waste water ameliorate cognitive deficits and neuropathology.Impairments of neural circuit function in Alzheimer's disease.Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer's Disease.Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in Aβ-Bearing Mice.Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer's Disease.Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer's disease mouse model.Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models.Amyloid Associated Intermittent Network Disruptions in Cognitively Intact Older Subjects: Structural Connectivity Matters.Rescue of long-range circuit dysfunction in Alzheimer's disease models.Arc illuminates Alzheimer's pathophysiology.Amyloid-β disrupts ongoing spontaneous activity in sensory cortex.Intracellular Ca2+ stores control in vivo neuronal hyperactivity in a mouse model of Alzheimer's disease.[Mechanisms of Alzheimer's disease : Neuronal hyperactivity and hypoactivity as new therapeutic targets].Elucidating the Interactive Roles of Glia in Alzheimer's Disease Using Established and Newly Developed Experimental Models
P2860
Q28081435-2D3C2F16-F26D-4B1A-8FCA-6A0899575BE3Q30539682-2ACF78D4-61D3-4823-B03E-CCF5D089F42AQ30564297-CCA525E4-E728-45B5-95FB-FEA7C0B60CEAQ30829062-2C424FE7-063D-4DAC-A050-1E4FC9210604Q30836664-662537FA-6345-48C0-9150-078967838E5FQ33740069-1703F692-47E2-444A-B732-556974267E36Q34451907-32ECD08A-6370-4BCE-80DE-FCF9B2761B2BQ34950366-08456272-6782-4450-9A0F-FDD959B4EC59Q35684738-390BB181-A9A4-40A8-84E7-811866D19544Q36304325-39BF4B9E-BBF7-4915-9539-43B69E7F3C15Q36799532-F93A4CFF-92BF-487A-9233-C365949844B3Q37270362-E982BC20-1E2D-4DD4-BD1A-1EB0BFF7CE5BQ37366766-14CF7A92-8983-4EF0-8FB6-695C2C5C052DQ37715875-76EB299D-8329-44AA-9D76-E6844DAAD5D0Q38069573-FCA1E6C2-3F94-4DD6-B335-409D9BD76644Q38189691-A840D28A-BBAB-48E1-911C-900F2374C5E3Q38198632-EA595961-F959-4CE3-A8FC-F128E96CA74BQ38379006-225D5BA9-E44A-4726-B2B5-167304EC93D8Q38461098-54B68421-283E-4EA7-8202-C3D9C4124897Q38663691-4E638633-7D65-4266-ACA4-A3B26236557BQ38821665-7F82AD42-1258-4445-819A-FCC436801C48Q38885836-112C77A0-691A-498C-BAE3-51AEE6312DA8Q39339952-E76F02B0-3E03-4B93-8D85-9A918EEF9D16Q40179990-4A41483F-0F97-4B10-83A4-688E8A4C1AACQ42328548-957F0EDE-9243-431C-BF5C-1D0A614C175DQ44364247-912736AA-286D-46C9-99B0-57D4BF809E29Q45021910-272AB8C5-661A-41CE-8C09-6C38C30E253CQ47194750-1826F8EF-3FCE-402F-B916-0FEAF42919B2Q47928098-01A0B319-1949-46BA-8FFC-17C9FFFED781Q48364770-01EE2BA1-AB0B-4706-A05F-0086BE285E25Q48407035-DA4E0B87-BE44-4FE8-A9E8-E0CE9EB8C15BQ49873932-5563C7E3-BB9B-42A8-BCD0-F97172FEE783Q53372356-CDAD1B36-0284-4A94-B651-0366A12D09CDQ57491513-053D7471-A8BB-42FF-B418-45BB672D54FB
P2860
Staged decline of neuronal function in vivo in an animal model of Alzheimer's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Staged decline of neuronal function in vivo in an animal model of Alzheimer's disease.
@ast
Staged decline of neuronal function in vivo in an animal model of Alzheimer's disease.
@en
type
label
Staged decline of neuronal function in vivo in an animal model of Alzheimer's disease.
@ast
Staged decline of neuronal function in vivo in an animal model of Alzheimer's disease.
@en
prefLabel
Staged decline of neuronal function in vivo in an animal model of Alzheimer's disease.
@ast
Staged decline of neuronal function in vivo in an animal model of Alzheimer's disease.
@en
P2093
P2860
P356
P1476
Staged decline of neuronal function in vivo in an animal model of Alzheimer's disease.
@en
P2093
Christine Grienberger
Daniel N Hill
Helmuth Adelsberger
Horst A Henning
Julia Reichwald
Nathalie L Rochefort
P2860
P2888
P356
10.1038/NCOMMS1783
P407
P577
2012-04-10T00:00:00Z